Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Sclerosing Solutions MeSH Descriptor Data 2025


MeSH Heading
Sclerosing Solutions
Tree Number(s)
D26.776.708.822
D27.505.954.411.700
D27.505.954.578.822
D27.720.752.822
Unique ID
D012597
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D012597
Annotation
coordinate /‌ther use with disease /‌ther, not disease /‌drug ther
Scope Note
Chemical agents injected into blood vessels and lymphatic sinuses to shrink or cause localized THROMBOSIS; FIBROSIS, and obliteration of the vessels. This treatment is applied in a number of conditions such as VARICOSE VEINS; HEMORRHOIDS; GASTRIC VARICES; ESOPHAGEAL VARICES; PEPTIC ULCER HEMORRHAGE.
Entry Version
SCLEROSING SOL
Entry Term(s)
Injections, Sclerosing
Sclerosant
Sclerosants
Sclerosing Agent
Sclerosing Agents
Sclerosing Drugs
Sclerosing Injection
Sclerosing Injections
Sclerosing Solution
Registry Numbers
0
See Also
Sclerotherapy
Date Established
1966/01/01
Date of Entry
1999/01/01
Revision Date
2020/05/27
Sclerosing Solutions Preferred
Sclerosing Agents Narrower
Sclerosing Drugs Narrower
Sclerosing Injections Narrower
page delivered in 0.143s